Skip to main content
Figure 5 | Retrovirology

Figure 5

From: Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants

Figure 5

No difference in the efficiency of viral entry between Env virus variants from the milk of transmitting and nontransmitting women, or postnatally infected infants. (A) Infectivity ratio (TCID50/ml divided by p24 amount in ng/ml) of Env virus variants; (B) Inhibition of Env virus variant infectivity by CCR5 antagonist Maraviroc; (C) Inhibition of membrane fusion by entry inhibitor T20 peptide. Lines represent means IC50s (performed in duplicate for each virus) for each group of Env variants.

Back to article page